Sep 7, 2023, 08:19 AM by

Intellegens, a company applying machine learning (ML) to accelerate innovation in R&D, has secured a £1.6m grant from Innovate UK, part of UK Research and Innovation (UKRI), to apply ML in the emerging field of oligonucleotide therapies. In collaboration with the Centre for Process Innovation (CPI), the two-year project will augment and validate the company’s ML technology, Alchemite™, as a tool to enhance productivity and yields of oligonucleotide therapeutic manufacture through performance prediction and optimisation of quality control strategies.

Sep 7, 2023, 08:19 AM by

Lactabico, an innovative biotech startup, has announced its graduation from the prestigious German Accelerator, a leading institution dedicated to propelling the growth of startups in the biotechnology sector.

Sep 6, 2023, 14:45 PM by

About Recipharm Recipharm is a leading Contract Development and Manufacturing Organisation (CDMO) in the pharmaceutical and biopharmaceutical industry employing almost 9,000 employees. Recipharm offers manufacturing services of pharmaceuticals in various dosage forms, production of clinical trial material and APIs, pharmaceutical and biologics product development, and development and manufacturing of medical devices. Recipharm manufactures several hundred different products for customers ranging from big pharma to smaller research and development companies. The company operates development and manufacturing facilities in France, Germany, India, Israel, Italy, Portugal, Spain, Sweden, the UK, and the US and is headquartered in Stockholm, Sweden. For more information on Recipharm and our services, please visit www.recipharm.com About Ahead Therapeutics Ahead Therapeutics is a start-up biotech company that uses proprietary technology to develop treatments for different autoimmune disorders. Ahead Therapeutics has developed an innovative solution based on the use of PS-liposomes containing autoantigens. These liposomes can induce antigen-specific immune tolerance through a biomimetic process, thereby interrupting the autoimmune reaction. Simply by changing the encapsulated autoantigen, Ahead’s technology can address the treatment of different auto-immune diseases: Type 1 Diabetes; Multiple Sclerosis; and Celiac Diseases, among others. For more information, please visit www.aheadtherapeutics.com Recipharm AB Corporate identity number 556498-8425 Address Box 603, SE-101 32 Stockholm, Sweden, Telephone +46 8 602 52 00 www.recipharm.com

Sep 5, 2023, 13:47 PM by User Not Found

Bio-IT World | Illumina today announced that its Board of Directors has appointed Jacob Thaysen, Ph.D., senior vice president of Agilent Technologies and president of its Life Sciences and Applied Markets Group, as Illumina’s next Chief Executive Officer, effective September 25, 2023.

Sep 5, 2023, 01:00 AM by User Not Found

Bio-IT World | Researchers in the U.S. and Sweden have identified a biomarker (MTBR-tau243) for Alzheimer’s disease that tracks with the amount of damaging tau tangles in the brain and, when combined with a specific phosphorylated tau species (p-tau205), is nearly as predictive of cognitive function as tau-positron emission tomography (tau-PET) imaging.

Aug 31, 2023, 01:00 AM by User Not Found

Bio-IT World | University of Missouri researchers developed an innovative method using nanopores; Oxford Nanopore speeds basecalling for MinKNOW; Standigm and Nashville Biosciences partner on early drug discovery research, and more.

Aug 30, 2023, 09:06 AM by

National Initiative to Educate Patients, Drive Awareness, & Raise Funds for ZERO Prostate Cancer; Donation Made for Every Fact Sheet Downloaded at PSAonPSA.com

Aug 30, 2023, 09:06 AM by

Aug 30, 2023, 09:06 AM by

Aug 30, 2023, 09:06 AM by

Aug 30, 2023, 09:06 AM by

Aug 30, 2023, 09:06 AM by

oseMe, a leading provider of precision dosing software for therapeutic drug monitoring (TDM) and creators of DoseMeRx and DoseMe Analytics, today announced AC Camargo Cancer Center continues to recognize improved patient care with real world data dosing results.

Aug 30, 2023, 01:00 AM by User Not Found

Bio-IT World | Cellares will use funding to launch the world’s first commercial-scale IDMO Smart Factory; Genesis Therapeutics plans to use Series B financing to elevate into a clinical stage company and further invest in its AI platform; Amber Bio will use funds to advance first-of-its-kind RNA editing platform; more.

Aug 29, 2023, 09:05 AM by

Aug 29, 2023, 01:00 AM by User Not Found

Bio-IT World | When the first human genome was sequenced, Jeanne Kehren switched from veterinary medicine to the pharmaceutical industry. After that “magical moment of hope,” Kehren and her colleagues looked forward to a bright future for individualized medicine and treatment.

Aug 28, 2023, 09:05 AM by

BOC Sciences, a leading supplier of research chemicals and custom services, has unveiled its innovative XDC bioconjugation platform, providing a significant tool for drug delivery.

Aug 28, 2023, 09:05 AM by

Creative Biolabs updated its NAA solution, which was designed to provide invaluable insights into autoimmune diseases and autoantibody profiling and promises to propel the field of autoimmune research forward.

Aug 24, 2023, 09:03 AM by

Aug 24, 2023, 08:55 AM by

Aug 24, 2023, 08:55 AM by

IntelliGuard, a provider of medication and inventory management solutions, is strengthening its leadership team with the appointment of Bob Howard as Chief Executive Officer and Tom Koning as President. Founded in 2006, San Diego-based IntelliGuard provides hospitals with a more efficient and effective system for tracking, tracing, and managing medications and critical inventory to improve patient safety. Their approach to inventory management is particularly relevant right now with ongoing drug shortages.